![Rachel King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rachel King
Direktor/Vorstandsmitglied bei NOVAVAX, INC.
Vermögen: 292 138 $ am 31.10.2025
Profil
Rachel K.
King was the founder of GlycoMimetics, Inc. since 2003, serving as Director from 2021 to 2025.
Current jobs include Independent Director at Novavax, Inc. since 2018, Director at MdBio, Inc., Director at University of Maryland Biopark, Director at Learning Undefeated, Inc., and Independent Director at Fulcrum Therapeutics, Inc. starting in 2024.
Former jobs include Chief Executive Officer at Genetic Therapy, Inc. from 1996 to 1998, President, Chief Executive Officer & Director at Biotechnology Innovation Organization from 2022 to 2024, Director at Warp Drive Bio, Inc., Executive Vice President at ALZA Corp., Senior Vice President at Novartis Corp.
from 1999 to 2001, Principal at Bain & Co., Inc., and Principal at NEA Management Co. LLC from 2009 to 2012.
Education includes an undergraduate degree from Dartmouth College and an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVAVAX, INC. 0,02 % | 20.06.2025 | 25.190 ( 0,02 % ) | 211 596 $ | 31.10.2025 |
0,05 % | 07.02.2025 | 6.317 ( 0,05 % ) | 80 542 $ | 31.10.2025 |
| 26.06.2025 | 0 ( -.--% ) | - $ | 31.10.2025 |
Aktuelle Nachrichten zu Rachel King
Aktive Positionen von Rachel King
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | Direktor/Vorstandsmitglied | 01.11.2018 |
| FULCRUM THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 12.11.2024 |
MdBio, Inc.
 MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services Non-profit bioscience networking and business development organization | Direktor/Vorstandsmitglied | - |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
University of Maryland Biopark
 University of Maryland Biopark Operates as bio-medical research centre | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Rachel King
| Unternehmen | Position | Ende |
|---|---|---|
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Gründer | 21.02.2025 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Vorstandsvorsitzender | 04.03.2024 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Vorstandsvorsitzender | 01.12.1998 |
| ░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Rachel King
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
ALZA Corp.
 ALZA Corp. Provides and develops pharmaceutical products | |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm that advises leaders on strategy, marketing, organization, operations, IT and M&A | Commercial Services |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services Non-profit bioscience networking and business development organization | Commercial Services |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Commercial Services |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Focuses on proprietary genomic technology to discover drugs of natural origin | |
Harvard Business School
 Harvard Business School Functions as a College/University | |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Develops medicines for patients by transforming gene regulation in disease | |
University of Maryland Biopark
University of Maryland Biopark Operates as bio-medical research centre | |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Functions as a foundation or endowment |
